The Addiction archive
 The Addiction archive

Addiction web site. Opens new Window

Effectiveness bank home page. Opens new window Collection
The Addiction archive

Analyses of articles in the journal Addiction published by our partner the Society for the Study of Addiction starting with the most recently published article, totalling today 75 documents.

Click blue titles to view full text in a new window
Use the selectors at the bottom to turn to the next page in the list of documents



STUDY 2015 HTM file
The effectiveness of brief alcohol interventions delivered by community pharmacists: randomized controlled trial

Dhital R., Norman I., Whittlesea C. et al.
Addiction: 2015, 110(10), p. 1586–1594.
Despite a clear rationale for embedding brief interventions in community pharmacies, this UK trial found no evidence that they would reduce hazardous or harmful drinking.

STUDY 2015 HTM file
Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England

Pierce M., Bird S.M., Hickman M. et al.
Addiction: 2015, 111, p. 298–308.
Implication of this English study is that to save the lives of people dependent on heroin or similar drugs, they should be engaged and retained in substitute prescribing programmes like methadone maintenance until there is little risk of their relapsing after leaving. Shortly after leaving residential/inpatient settings was the highest risk period.

STUDY 2015 HTM file
Fatal opioid poisoning: a counterfactual model to estimate the preventive effect of treatment for opioid use disorder in England

White M., Burton R., Darke S. et al.
Addiction: 2015, 110, p. 1321–1329
First robust analysis estimates that between 2008 and 2011, 880 opioid-related ‘overdose’ deaths were prevented each year by addiction treatment in England, reducing total deaths by over 40%.

STUDY 2015 HTM file
Can cannabis use be prevented by targeting personality risk in schools? Twenty-four-month outcome of the adventure trial on cannabis use: a cluster-randomized controlled trial

Mahu I.T., Doucet C., O’Leary-Barrett M. et al.
Addiction: 2015, 110, p. 1625–1633.
School staff trained to deliver personality-targeted substance use interventions to London high school pupils – effectively delaying cannabis use among a subset (those identified as ‘sensation-seekers’).

REVIEW 2014 HTM file
Prize-based contingency management for the treatment of substance abusers: a meta-analysis

Benishek L.A., Dugosh K.L., Kirby K.C. et al.
Addiction: 2014, 109(9), p. 1426–1436.
Systematically giving substance use patients a chance to win valuable prizes if they test abstinent offers a lower-cost alternative to ‘contingency management’ systems which provide rewards each time, but does it work? Across 18 studies the answer was ‘Yes,’ though effects soon faded.

STUDY 2014 HTM file
An early evaluation of implementation of brief intervention for unhealthy alcohol use in the US Veterans Health Administration

Williams E.C., Rubinsky A.D., Chavez L.J. et al.
Addiction: 2014, 109(9), p. 1472–1481.
Evaluated across an entire region, a determined effort to implement alcohol screening and brief intervention in the US health system for ex-military personnel led to no significant reductions in drinking – results seen as a prime example of the disappointing impacts of alcohol brief interventions in real-world conditions.

STUDY 2014 HTM file
Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial

Holland R, Maskrey V., Swift L. et al.
Addiction: 2014, 109(4), p. 596–607.
A randomised trial conducted in England found that the (at the time) recommended three months of supervised consumption of prescribed opioid substitutes like methadone conferred no significant advantages over supervising only for up to the first four weeks of treatment, but the findings applied only to the minority of patients for whom random allocation was thought feasible and safe.

REVIEW 2013 HTM file
Metaanalysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?

Maisel N.C., Blodgett J.C., Wilbourne P.L. et al.
Addiction: 2013, 108(2), p. 275–293.
Naltrexone and acamprosate both modestly curtail drinking among alcohol-dependent patients, but which is best in which circumstances and for which treatment goals? To find out this review compared the medications’ performance when separately benchmarked against a placebo, bringing to bear much more data than is available from the few trials which directly compared the two drugs.

STUDY 2012 HTM file
Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence?

Vickerman P., Martin N., Turner K. et al.
Addiction: 2012, 107, p. 1984–1995.
Among the messages of this simulation model for the UK and other countries is the resilience of hepatitis C in the face of considerable investment in methadone and needle exchange services, that these have nevertheless helped and need to be maintained and if possible expanded, but also that further measures are required to substantially curtail the virus.

STUDY 2012 HTM file
Double-blind placebo-controlled evaluation of the PROMETATM protocol for methamphetamine dependence

Ling W., Shoptaw S., Hillhouse M. et al.
Addiction: 2012, 107(2), p. 361–369.
The US company which owns and markets the controversial PROMETA proprietary combination of drugs for methamphetamine dependence funded a rigorous trial by independent researchers; the result was a no-better-than-placebo verdict, another negative in the search for drugs to counter stimulant dependence.


Select search results page

PREVIOUS | NEXT 1 2 3 4 5 6 7 8